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Abstrac~ Native Acacia c~nfusa trypsin inh~bit~r ( ACTI) contains t~ disu~phide b~nds; ~ne is an intrachain disu~phide b nd (Cys4~-Cyss6)~ ~ocated 
in the A-chain, while the other is an interchain disulphide bond (Cysm33-Cys141) connecting the A- and B-chain; the inhibitor consists of 175 amino 
acid residues, 136 residues in the A-chain and 39 residues in the B-chain. The putative reactive site of ACTI is located at Lys ~, while for all other 
Kunitz family trypsin inhibitors it is at Arg ~*. When the Lys ~ residue ofACTI was converted into lie or Arg by site-specific mutagenesis, the K64I 
mutant completely lost its inhibitory activity but the K64R mutant retained most f its inhibitory activity. The C133G mutant lost its inhibitory activity 
while the C40G mutant did not. This suggests thatthe interchain disulphide bond (Cysm-Cys TM) linking two fl-strands of the six-strand ~-barrd 
is essential for ACTI inhibitory activity, while the intrachain disulphide bond (Cys4°-Cys 86) connecting the two loops is non-essential. 
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1. Introduction 
Acacia confusa trypsin inhibitor (ACTI) is a Kunitz family 
two-chain trypsin inhibitor with a Mr of 194 kDa, having 175 
amino acid residues and consisting of A- and B-chains of 136 
and 39 residues, respectively [1]. The primary structure of ACTI 
has been elucidated [2], and has a high degree of homology to 
the other Kunitz family trypsin inhibitors from soybean [3], 
winged bean seeds [4], and Erythrina latissima seeds [5]. The 
nucleotide sequence of the eDNA for ACTI has been deter- 
mined, and an extra amino acid residue, serine, was found at 
the junction of the A- and B-chain, which was removed by 
post-translational processing with specific protease(s) [6]. The 
reACTI, a single polypeptide chain, without post-translational 
processing by proteolysis i  biologically active [7]. ACTI has 
Lys 64 located at its reactive site, and there are two disulphide 
bonds, the interchain disulphide bond Cys133-Cys ~4~, linking 
4O 86 two fl-strands, and the interchain disulphide bond, Cys -Cys . 
The ACTI cDNA has been cloned and expressed in E. coli and 
it was found that reACTI is a single polypeptide chain with a 
strong inhibitory effect on trypsin activity without post-transla- 
tional proteolysis [7]. 
In the present study we used site-specific mutagenesis and 
cDNA expression i E. coli to characterize tbe biological prop- 
erties of several ACTI mutants. 
2. Materials and methods 
2.1. Materials 
Restriction enzymes and other reagents used in molecular biology 
techniques were purchased from Pharmacia LKB Biotechnology 
(Uppsala, Sweden) or Promega (Madison, WI, USA). The pBS(+) 
plasmid was obtained from Stratagene (La Jolla, CA, USA). All other 
chemicals used were of analytical grade. 
2.2. Site-specific mutagenesis 
The plasmid containing the cDNA insert of ACTI, pBSACTI (wild- 
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type) [7], was modified by site-specific mutagenesis, and then by PCR 
to generate mutated eDNA. The oligonucleotide primers synthesized 
to have the first 8 N-terminal amino cids f the ACTI A-chain with 
a BamHI restriction site (primer A), the last 8 C-terminal amino acids 
of the ACTI B-chain with a stop codon (complement of UAA) and an 
EcoRI restriction site (primer B), and DNA fragments containing the 
amino acid conversions Lys~-->Ile, Lys~4~Arg, Cys4°~Gly and 
Cys133~Gly (primers C, D, E and F, encoding the 6 amino 
acids of mutants containing a site-specific mutation, K64I, K64R, 
C40G and C133G, respectively), were as follows: 
Pr imer  A 5 ' -AGGATCCAAAGAACTTCTGGACGCAGACGGG-3  ' 
P r imer  B 5 ' -CTTTTCCGGGTAGCCAGTCCCATTCTTAAGG-3  ' 
P r imer  C 5' ~CCACCTATAATTGCAATT-3  ' 
P r imer  D 5' -CCACCTAGAATTGCAATT-3  ' 
Pr imer  E 5' -CGAAAGCGGCCCTCTC-3  ' 
P r imer  F 5 ' -TGTTTACGGTGAAGGT-3  ' 
All mutants were confirmed bysequencing the ligation products f 
Bluescript plasmids containing the mutated eDNA byusing the dide- 
oxynucleotide chain-termination method [8] with T7 DNA polymerase. 
2.3. Construction f expression plasmids 
The primers were used for PCR on the Bluescript plasmids (mutants) 
to generate ACTI-encoding DNA fragments for subeloning. DNA
fragments encoding 176 amino acids of ACTI (wild-type and mutants) 
flanked by EcoRI and BamHI sites, were ligated into pGEX-2T with 
T4 DNA ligase. The desired expression vector was identified by colony 
hybridization and the orientation f each insert was confirmed by 
nucleotide sequencing. These expression plasmids were designated 
pGAEX-2T (wild-type), pGM1EX-2T(K64I), pGM2EX-2T(K64R), 
pGM3EX-2T(C40G) and pGM4EX-2T(C133G), respectively. 
2.4. Transformation and purification of GST fusion proteins 
The E. coli TG1 cells were transfected with wild-type and mutant 
plasmids by CaC12-mediated ransformation. The culture cells at a cell 
density of 4 × 108 cells/ml were induced with 0.5 mM isopropyl ]/-o- 
thiogalactopyranoside for 3 h and lysed on ice by mild sonication after 
addition of Triton X-100 to 1%. The fusion proteins were purified by 
affinity chromatography with a glutathione-Sepharose 4B column 
[1,9,10]. The purified fusion proteins were cleaved from the GST lead r 
peptide with thrombin (1:50 w/w) and the reaction products were 
purified with a FPLC Mono Q column (1.6 × 50 mm) which was pre- 
equilibrated with 50 mM Tris-HC1 buffer (pH 8.0) and then eluted with 
a 0--0.3 M NaCI gradient in the same buffer. 
2.5. Analysis of expressed proteins 
The purified reACTI (wild-type), K64I mutant, K64R mutant, C40G 
mutant and C133G mutant were subjected to SDS-PAGE [11]. The 
N-terminal amino acid sequence of reACTI was analyzed directly with 
an ABI 477A sequencer and ABI 120A analyzer using about 1 nmol 
0014-5793/94/$7.00 © 1994 Federation of European Biochemical Societies. All fights reserved. 
SSDI  0014-5793(94)01066-8 
C.-H. Hung et al./FEBS Letters 353 (1994) 312-314 313 
of reACTI. The protein was quantitatively determined by the method 
of Lowry [12]. 
2.6. Inhibition of trypsin 
The trypsin inhibitory activity of mutants and wild-type ACTI was 
measured by incubating the recombinant ACTIs with trypsin in 1 ml 
of 0.1 M Tris-HC1 buffer, pH 8.0, containing 0.01 M CaCI2 for 5 min 
at 37"C. Residual trypsin activity was determined by adding 10/~1 
N~-benzoyl-L-arginine-4-nitro-anilide hydrochloride (L-BAPNA) 
(50 mg/ml in DMSO) at 37"C. After 20 rain incubation, the reaction 
was stopped by adding 0.5 ml 10% acetic acid. The degree of inhibition 
was determined by measuring the optical density at 410nm. 
3. R ~  
3.1. Construction of mutant ACT!  cDNA 
The primary structure of ACTI was elucidated recently. It 
contains two disulphide bonds, Cysa°--Cys s6 and Cys~33-Cys TM, 
and the putative reactive site of ACTI was found to be Lys 64 
[3]. Two mutant plasmids, pGM1EX-2T to produce mutant 
K64I mutant, and pGM2EX-2T to produce mutant K64R mu- 
tant, were prepared to study the effects of these mutations on 
trypsin inhibitory activity. Two other mutant plasmids, 
pGM3EX-2T for the C40G mutant, and pGM4EX-2T for the 
C133G mutant, were also constructed to investigate the role of 
the disulphide bond on trypsin inhibitory activity. The muta- 
tions of ACTI by site-specific mutagenesis were confirmed by 
nucleotide sequence analysis of mutant plasmids. 
3.2. Purification of mutant ACTIs 
The reGST-ACTI fusion proteins were obtained by the ex- 
pression of mutant plasmids in E. coli TG1 cells. The fusion 
proteins were purified from the E. coli lysate by affinity chrom- 
atography with a glutathione-Sepharose 4B column. The puri- 
fied fusion proteins were then treated with thrombin and fol- 
lowed by purifying with a Mono Q column. Two peaks were 
obtained and the first peak eluted with 0.06 M NaC1 was iden- 
tified as reACTI. The homogeneity ofpurified mutant reACTIs 
was analyzed by SDS-PAGE and the results are summarized 







Fig. 1. SDS-PAGE in 12% polyacrylamide showing the expression and 
purification of reACTI and its mutants. Lane 1-8 were run without 
reduction. Lane 1, the fusion protein, reGST-ACTI, was purified on a 
glutathione-Sepharose 4B column. Lane 2, reGST-ACTI was endopro- 
teolytically cleaved with thrombin. Lane 3, purified reGST. Lane 4, 
purified reACTI (wild-type). Lane 5, purified K64I mutant. Lane 6, 
purified K64R mutant. Lane 7, purified C40G mutant. Lane 8, purified 
C133G mutant. Lane 9, reACTI treated with 5% fl-mercaptoethanol in 
50 mM Tris-HCl buffer, pH 8.0, at 37°C for 1 h. 
in Fig. 1. The N-terminal amino acid sequence of mutant 
reACTIs was determined with an automated sequencer, and the 
results indicated that mutant reACTIs have the same N-termi- 
nal amino acid sequence (about 18 amino acid residues) as that 
of native ACTI (data not shown). The K64I, K64R and C40G 
mutants had the same electrophoretic mobility as that of native 
ACTI, while the C133G mutant exhibited slower mobility than 
that of reduced reACTI. 
3.3. Trypsin inhibitory activity of mutant ACTIs 
The ICs0 of native and reACTI trypsin inhibitory activity was 
shown to be identical. The effects of various missense mutants 
of ACTI on the trypsin inhibitory activity were shown in Fig. 
2. The results howed that the single amino acid change of the 
active site, Lys 64---> Arg, does not significantly affect the inhib- 
itory activity of the K64R mutant, while the substitution 
Lys~--->Ile, the K64I mutant, almost abolishes the trypsin in- 
hibitory activity. No detectable inhibitory activity was found 
in the C133G mutant, and no significant inhibitory activity 
change was observed in the C40G mutant. The Ki values with 
trypsin of the mutants, K64R, C40G, C133G, K64I, and wild- 
type reACTI were determined to be 1.024, 0.934, 29793, 27432 
and 0.274 nM, respectively. 
4. Discussion 
The primary structures of many Kunitz family trypsin inhib- 
itors have been elucidated, and most of them have an Arg 
residue at the reactive site [4,5,13]. However, ACTI has Lys 64 
at its putative reactive site. Site-specific mutagenesis was car- 
tied out to confirm the reactive site of ACTI. The Lys64--->Ile 
substitution resulted in the complete loss of trypsin inhibitory 
activity, while with the conservative Lys~*--->Arg substitution 
there was no significant change in inhibitory activity. This sug- 
gests that either Arg or Lys at the reactive site is essential for 
the Kunitz family trypsin i hibitor activity. 
There are two disulphide bonds Cys4°-Cys s6 and 
Cys]33-Cys TM, in ACTI, which are conserved in soybean trypsin 
inhibitor [13], winged bean trypsin inhibitor [4,14], Erythrinus 
caffra trypsin inhibitor [15], and Adenanthera pavonina trypsin 
inhibitor [16]. A Cys ~ Gly exchange by site-specific mutagene- 
sis causes the disruption of the disulphide bond of the mutant 
protein: thus it may induce an unfolding or a conformational 
change of protein structure and affect its biological activity. 
The single amino acid substitution Cyst33--+ Gly resulted in the 
complete loss of inhibitory activity, while the Cys4°--*Gly 
substitution did not. This suggests that the disulphide bond 
Cys133--Cys t4t is essential for ACTI inhibitory activity, but that 
Cys4°-Cys s6 is not. The conformational change in mutant 
C133G is also apparent from its electrophoretic mobility, since 
the mutant C133G loses its interchain disulphide bond. 
It was shown previously that the single chain of reACTI is 
as biologically active as the two-chain ative ACTH [7]. Dis- 
ruption of the interchain disulphide bond (Cys133-Cys 141) 
causes the dissociation of two polypeptide chains of native 
ACTI but not of reACTI since reACTI is a single polypeptide 
chain without post-translational processing by proteolysis. This 
suggests that there is refolding of the molecule and functioning 
of native disulphide bonds. For the C133G mutant 
(Cystaa-->Gly), non-native intramolecular disulphide bonds 
Cys]41~Cys 4° and Cys141~Cys 86 may have formed [17,18]. 
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Fig. 2. Trypsin inhibitory activity of ACTI, reACTI and mutant proteins. (A) The effects of mutants K64I and K64R on trypsin activity. (B) The 
effects of mutants C40G and C133G on trypsin activity. 
However, the similar mobility between non-reduced C133G 
mutant and reduced native-like reACTI observed in SDS- 
PAGE strongly suggests that the C133G mutant has no dis- 
ulphide bonds at all, forming a non-native and inactive mole- 
cule. For the C40G mutant (Cys 4°---)Gly), one may expect non- 
native intramolecular disulphide bonds CysS6-Cys 133 and 
CysS6-Cys TM to have formed. However, the similar trypsin in- 
hibitory activity and mobility in SDS-PAGE of the C40G mu- 
tant and reACTI suggests that proper refolding of the C40G 
mutant and the formation of the disulphide bond, Cys 133- 
Cys m, takes place. 
The X-ray crystallography of two Kunitz family trypsin in- 
hibitors from Erythrina caffra seeds [19] and soybean [20,21] 
were elucidated. Both trypsin inhibitors have 12 antiparallel 
t-strands joined by several loops. The inhibitor shows approx- 
imately 3-fold symmetry about the axis of the barrels formed 
by t-strands. The amino acid sequence of ACTI shows a high 
degree of homology to those of the Kunitz family trypsin inhib- 
itors isolated from soybean and Erythrina caffra seed [2]. Ac- 
cordingly, the two disulphide bonds in the reACTI molecule are 
the disulphide bond (Cys4°-Cys 86) linking two loops and the 
disulphide bond (Cys133---fys TM) connecting two t-strands of 
the six strand t-barrel according to the 3D structure of soybean 
or Erythrina caffra trypsin inhibitors. The C133G mutant lost 
its inhibitory activity, strongly suggesting that the linkage be- 
tween the two antiparallel t-strands (C1 and C2 designated by 
Onesti et al. [19], for Erythrina caffra trypsin inhibitor) is essen- 
tial for maintaining the tertiary structure of ACTI and its tryp- 
sin inhibitory activity. When the intrachain disulphide bond 
Cys4°--Cys 86 was split, the C40G mutant conserved its inhibitory 
activity, suggesting that the linkage between the two loops was 
not important for maintaining its intact structure and inhib- 
itory activity. 
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